Form 4: Arvinas Director Edward Moore Kennedy Jr. Reports Changes in Beneficial Ownership

Director Edward Moore Kennedy Jr. reports acquisition of restricted stock units and stock options in Arvinas, Inc.

Summary

• On May 29, 2024, Edward Moore Kennedy Jr., a director of Arvinas, Inc., reported changes in his beneficial ownership of the company's stock.
• He acquired 5,899 shares of common stock through restricted stock units (RSUs) and 9,070 shares through stock options.
• The RSUs and stock options vest on the earlier of May 29, 2025, or the first board meeting after the next annual stockholder meeting.
• Kennedy also reported indirect ownership of 29,333 shares held in the Edward M. Kennedy Jr. 2011 Trusts For Children (UAD 11/23/11).
• He disposed of 23,405 shares of common stock.

Sentiment

Score: 5

Explanation: The document itself is neutral, simply reporting transactions. The mix of acquisitions and disposals makes it difficult to assess a clear positive or negative sentiment.

Positives

• The acquisition of RSUs and stock options by a director could be seen as a positive signal, indicating confidence in the company's future performance.

Negatives

• The disposal of 23,405 shares of common stock by the director could be seen as a negative signal.

Risks

• The vesting of the RSUs and stock options is contingent upon future events, including the timing of the annual stockholder meeting and board meetings.
• Changes in market conditions or company performance could affect the value of the acquired securities.

Future Outlook

The vesting of the RSUs and stock options is contingent on future events, specifically the timing of the annual stockholder meeting and subsequent board meetings.

Industry Context

This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. It's common for directors to receive stock options and RSUs as part of their compensation.

Comparison to Industry Standards

• Director compensation packages often include a mix of salary, stock options, and restricted stock units.
• Vesting schedules for stock options and RSUs typically range from one to four years, aligning with industry norms.
• The specific terms of these grants, such as the exercise price and vesting schedule, are generally comparable to those offered by similar companies in the biotechnology sector.

Stakeholder Impact

• The reported transactions may influence investor sentiment regarding the company's prospects.
• Employees holding company stock or options may be interested in the director's transactions.

Key Dates